Elena V. Borisova
Elena V. Borisova has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Igor V. Ivanov
Federal State Organization “Russian Scientific and Research Institute for Medical Engineering”, Federal Service for Surveillance in Healthcare (Roszdravnadzor), 115478 Moscow, Kashirskoye shosse 24, bld. 16, Russian Federation
1 shared publication - Maxim V. Gorelov
Pirogov Russian National Research Medical University
1 shared publication
Latest Publications
- Open Access
- 6 February 2026
- Published by ECO-Vector LLC (Publications) in N.N. Priorov Journal of Traumatology and Orthopedics
- Vol. 33 (2) , 366-375
Analysis of adverse events reported in the automated information system of the federal service for surveillance in healthcare for orthopedic medical devices, 2020–2025
BACKGROUND: The success of interventions in orthopedics and traumatology is largely determined by the performance of implantable medical devices. However, a substantial number of complications, including those occurring in the long term, affect patients’ quality of life. Adverse events directly attributable to implantable medical devices remain insufficiently studied, although their analysis is crucial for the development of a modern safety culture, improvement of the regulatory framework, and enhancement of the quality of medical care. AIM: The work aimed to assess the distribution of adverse events associated with the use of orthopedic medical devices in order to improve the medical device safety monitoring system. METHODS: A quantitative analysis of adverse events reported between 2020 and 2025 was performed, including evaluation by severity, outcome, types of adverse events, and causes of failure. Statistical analysis was conducted using descriptive methods, with calculation of absolute and relative (percentage) frequencies for each category. RESULTS: The analysis demonstrated that the largest number of adverse events recorded in the automated information system of the Federal Service for Surveillance in Healthcare during the period 2020–2025 was associated with the use of orthopedic medical devices, primarily joint endoprostheses and osteosynthesis systems. The obtained data confirm that these categories of devices account for the highest proportion of risks during clinical use, which is consistent with previously published studies. CONCLUSION: An objective analysis of data on the frequency of adverse events and their causes makes it possible to identify risk factors that were not taken into account at the stage of market authorization of medical devices, to revise accompanying documentation for medical devices, to implement measures to prevent the use of devices posing a threat to life and health, and ultimately to improve the quality of medical care.
- 6 February 2026
- Published by ECO-Vector LLC (Publications) in N.N. Priorov Journal of Traumatology and Orthopedics
- Vol. 33 (2) , 366-375
Open AccessAnalysis of adverse events reported in the automated information system of the federal service for surveillance in healthcare for orthopedic medical devices, 2020–2025
BACKGROUND: The success of interventions in orthopedics and traumatology is largely determined by the performance of implantable medical devices. However, a substantial number of complications, including those occurring in the long term, affect patients’ quality of life. Adverse events directly attributable to implantable medical devices remain insufficiently studied, although their analysis is crucial for the development of a modern safety culture, improvement of the regulatory framework, and enhancement of the quality of medical care. AIM: The work aimed to assess the distribution of adverse events associated with the use of orthopedic medical devices in order to improve the medical device safety monitoring system. METHODS: A quantitative analysis of adverse events reported between 2020 and 2025 was performed, including evaluation by severity, outcome, types of adverse events, and causes of failure. Statistical analysis was conducted using descriptive methods, with calculation of absolute and relative (percentage) frequencies for each category. RESULTS: The analysis demonstrated that the largest number of adverse events recorded in the automated information system of the Federal Service for Surveillance in Healthcare during the period 2020–2025 was associated with the use of orthopedic medical devices, primarily joint endoprostheses and osteosynthesis systems. The obtained data confirm that these categories of devices account for the highest proportion of risks during clinical use, which is consistent with previously published studies. CONCLUSION: An objective analysis of data on the frequency of adverse events and their causes makes it possible to identify risk factors that were not taken into account at the stage of market authorization of medical devices, to revise accompanying documentation for medical devices, to implement measures to prevent the use of devices posing a threat to life and health, and ultimately to improve the quality of medical care.